AccSys Technology’s first mobile PULSAR PET isotope production laboratory contains a shielded mini-cell housing, a synthesis unit for FDG and a clean area with a Class 3 laminar flow-hood for final dispensing. Another feature is a 7 MeV PULSAR proton linear accelerator installed in a mobile coach.
If you enjoy this content, please share it with a colleague
Related Content
July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...
July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...
June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...
June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...
April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...
January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...
According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...
January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...